Articles tagged with Pluripotent Stem Cells
Researchers in Canada have developed a technique to produce large quantities of endoderm cells from human pluripotent stem cells, overcoming a key hurdle in regenerative medicine. The method allows for significant increases in effective cell production, enabling the potential for regenerative treatments for diabetes and liver disease.
Researchers found that pluripotent stem cells respire at the same level as differentiated body cells but produce very little energy. UCP2 protein blocks respiration substrates from entering mitochondria, allowing glycolysis to dominate. The study suggests that changes in metabolism drive cell differentiation.
Scientists at the University of Georgia have developed a new method to create neural crest cells, precursors of bone cells, smooth muscle cells, and neurons, using a single-step process that reduces production time by half. The method uses small molecules to activate specific signaling pathways, increasing consistency and reducing costs.
Bioengineers at UC Berkeley have successfully reprogrammed mature muscle tissue, a major breakthrough in combating muscle degeneration. The researchers used small molecule inhibitors to de-differentiate mature muscle cells, allowing them to revert back to an earlier stem cell stage.
Scientists have found a control switch that regulates stem cell pluripotency by altering the DNA binding properties of FOXP1, facilitating maintenance of pluripotency and reprogramming adult cells. The discovery has significant implications for therapeutic applications in regenerative medicine and cancer research.
Researchers identified a protein that helps maintain mouse stem cell pluripotency by activating signal pathways via CC chemokine ligand 2 (CCL2). This finding offers insights into cultivating human iPS/ES cells without feeder cells, reducing the risk of contamination and health risks.
Researchers developed a method to generate patient-specific heart cells from hair follicles, enabling disease modeling and drug screening. This approach offers an alternative to existing methods using skin fibroblasts or bone marrow cells, which require surgical intervention.
Researchers found that human embryonic stem cell-derived cells bear striking differences from human tissue cells in gene expression, functionality, and appearance. The cells' developmental maturity is also a concern, particularly for transplantation and disease modeling, as they may not mature to the same levels as adult cells.
Researchers at Stanford University School of Medicine have developed a way to remove pluripotent human embryonic stem cells from their progeny before transplanted into patients. The technique uses antibodies to recognize and bind to only pluripotent cells, eliminating the risk of teratomas.
Human stem cells can be directed to specific cell types through molecular cues, enabling more efficient tissue regeneration. Researchers found that pluripotent stem cells have unique 'suitcases' for different destinations, increasing specialized cell production.
Researchers have successfully reprogrammed adult body cells into iPS cells, which can be taken directly from each patient and genetically redirected to replace ailing cells. While iPS technology holds promise, it still faces challenges and is not yet ready for widespread use.
Researchers at the Max Delbrück Center (MDC) have identified E-cadherin as a key molecule enabling embryonic stem cells to differentiate into diverse cell types. The study found that E-cadherin plays a crucial role in maintaining pluripotent stem cells and reprogramming somatic cells into induced pluripotent stem cells.
Researchers at Whitehead Institute have discovered that planarian flatworms possess pluripotent stem cells called clonogenic neoblasts, which can differentiate into various tissue types and even replace all tissues in a host. This finding has significant implications for understanding regeneration in mammals.
Researchers at Brown University have discovered new molecular interactions in stem cells that control their versatility, using a technology called MEGAShift. The study found that proteins compete and cooperate to produce complex bindings along DNA sequences.
Researchers at Georgetown University Medical Center have successfully created retinal cells derived from human-induced pluripotent stem cells that mimic the eye cells responsible for age-related macular degeneration. The discovery paves the way for potential treatment and regeneration therapies for this debilitating condition.
A new diagnostic test called PluriTest enables researchers to determine the quality of pluripotent stem cell lines with remarkable sensitivity and specificity. The test uses a detailed molecular model of normal pluripotent cells to identify genomic aberrations, alerting scientists to perform additional analysis.
Researchers at the University of Montreal have made a breakthrough in generating pluripotent stem cells from horses, paving the way for potential new treatments for human degenerative conditions. The discovery will aid the development of preclinical models leading to human applications.
Researchers have documented genetic abnormalities in human embryonic stem cells and induced pluripotent stem cells, including duplications near pluripotency-associated genes and deletions involving tumor suppressor genes. Frequent genomic monitoring of these cell lines is necessary to ensure their stability and clinical safety.
Researchers at University of Illinois found that soft gel substrates promote homogeneous pluripotent stem cell cultures without expensive growth chemicals. This discovery has huge applications in regenerative medicine, offering a step toward understanding the basic biology of stem cells.
Researchers at Georgetown University successfully generated human-derived islet cells from spermatogonial stem cells, demonstrating their potential to counter diabetic hyperglycemia. The bioengineered cells secreted insulin and exhibited markers characteristic of normal islet cells.
Researchers successfully created complex, functioning intestinal tissue in a lab using pluripotent stem cells, opening doors to unprecedented studies of human intestinal development and disease. The breakthrough also paves the way for therapeutic applications, including transplantation and drug absorption.
A team of scientists has discovered that microRNA profiles can predict the type of cell, including whether it's cancerous or not. This finding has significant implications for the use of stem cells in repairing damaged body parts, as it highlights the potential risks of creating cancer.
A research team at the University of Georgia has discovered a critical role for the cancer-causing gene Myc in stem cell biology, which could revolutionize medicine by enabling patient-specific stem cells. The study found that Myc sustains pluripotency by repressing a master regulator gene, and its absence triggers differentiation.
Researchers have successfully generated iPS cell-derived hepatocytes, which can recapitulate key features of inherited liver diseases and regenerate in mice. This breakthrough could lead to new treatments for liver disorders.
Researchers have isolated the first stage of tissue production in human embryonic stem cells, marking a significant breakthrough in regenerative medicine. The discovery may lead to the development of safer tissues for use in treating various medical conditions, including leukemia and sickle cell anemia.
Researchers at UNC Health Care have made a breakthrough in understanding the role of Tet 1 protein in maintaining stem cell pluripotency. The study found that Tet 1 helps stem cells renew themselves and stay undifferentiated, paving the way for personalized therapies.
Researchers have discovered that axolotls possess pluripotent cells in their embryos, similar to those found in mammals, offering a unique opportunity to study the properties of embryonic stem cells. This breakthrough supports the development of regenerative medicine and provides insights into the evolution of stem cell properties.
Researchers have identified a cluster of small RNA that correlates with pluripotency in induced-pluripotent stem cells, enabling the distinction of more viable cell lines. This discovery is expected to improve the production of full pluripotent iPS cells and their application in disease therapy.
A new strategy for reprogramming human adult cells into induced pluripotent stem (iPS) cells has been successfully developed, eliminating the need for oncogenes. This innovation offers improved safety and efficiency for producing patient-specific stem cells for therapeutic applications.
A recent study by Mount Sinai researchers demonstrates that skin cells found in human amniotic fluid can be efficiently 'reprogrammed' to pluripotency, a characteristic similar to human embryonic stem cells. This breakthrough has significant implications for stem cell research and patient care.
Researchers use minicircles to reprogram adult cells, achieving higher efficiency than viral vectors and introducing new hope for regenerative medicine applications. The discovery enables easier creation of induced pluripotent stem cells, which can be used to study human diseases and develop novel treatments.
Researchers at Stanford University School of Medicine have successfully converted mouse skin cells directly into functional nerve cells using just three genes. This breakthrough finding could revolutionize human stem cell therapy and change our understanding of cellular specialization.
A recent study developed a straightforward technique to determine the ethnic origin of stem cells, finding that Caucasian and East Asian populations are overrepresented in current cell lines. The team created a new stem cell line with a West African Yoruba genetic profile, which could lead to more diverse research and safer therapies.
A team of researchers has identified the Chd1 gene as a crucial regulator of open chromatin in embryonic stem cells, enabling their ability to differentiate into any cell type. The study provides important insights into the mechanisms of stem cell pluripotency and opens up new avenues for the development of stem cell therapies.
Researchers aim to use human pluripotent stem cells to produce cardiac myocytes for transplantation into diseased hearts. The study could potentially treat 500,000 new cases of heart disease annually.
The company has developed a 2-week method for generating human induced-pluripotent stem cells with a 200-fold increase in yield. This breakthrough has broad implications for pharmaceutical-grade iPSCs production without genetic modification at commercial scale.
Researchers from the University of Cambridge have identified a critical protein called Nanog that plays a pivotal role in creating pluripotent cells. By understanding how Nanog influences other molecules, scientists hope to develop more efficient and safe methods for harnessing stem cells for medical applications.
Researchers have successfully created various types of mature white blood cells from embryonic and adult stem cells, opening up new possibilities for studying disease development and treatment. The technique could produce cells tailored to specific infections or tumors, making it a potential tool for safety screening of new drugs.
A gene called Chd1 has been found to be critical in maintaining the pluripotent state of embryonic stem cells. This discovery could lead to a greater understanding of how cells acquire specialized states and provide a strategy for efficiently reprogramming mature cells back into the pluripotent state.
Researchers at Max-Planck-Gesellschaft have developed a method to convert adult testis cells in mice into pluripotent stem cells, which can form all types of body tissue, without the use of introduced genes, viruses, or reprogramming proteins. The culture conditions were found to be crucial for the success of the process.
Scientists have developed a new method to create safe and effective embryonic-like stem cells using tiny molecules called microRNAs. This breakthrough technology eliminates the risks associated with traditional DNA-based methods, making it a promising step towards regenerative medicine.
Scientists at Stanford University School of Medicine have identified a protein complex that plays a pivotal role in controlling the ability of embryonic stem cells to become any cell type. The finding is an important advance in harnessing the unique abilities of embryonic stem cells to treat disease and generate replacement tissue.
Eight UT Austin engineering professors win prestigious NSF CAREER awards, with funding of over $3.2 million to support cutting-edge research in fields like nanotechnology, energy systems, and biomedical engineering.
Scientists at Stanford University School of Medicine and UC-San Francisco have successfully isolated stem cells from human testes, which can differentiate into various types of tissues. The findings suggest that these cells are not as pluripotent as embryonic stem cells but have unique therapeutic applications.
Researchers have developed a method to create novel types of stem cells, offering opportunities for expanding research and drug discovery. The technique enables the creation of rat and human pluripotent stem cells with characteristics similar to mouse embryonic stem cells.
Researchers have identified two small molecule compounds, BIX and BayK, that can replace conventional reprogramming genes, enabling the selective reprogramming of general cells into pluripotent stem cells. This breakthrough technology offers a more precise control over the process and has distinct advantages over genetic manipulation.
Researchers at Tel Aviv University have developed a new classification system for identifying pluripotent stem cells in human tissue. By analyzing global gene expression profiles from 150 human stem cell samples, the team discovered a protein-protein network common to pluripotent cells, pointing to a key building block of their transfo...
Researchers at WPI aim to develop a novel method for transforming adult skin cells into stem-like cells using an extract from the African clawed frog. If successful, this could lead to treatments for degenerative diseases like diabetes and Parkinson's.
A UC Riverside researcher has developed a new method to culture human embryonic stem cells using no animal-derived materials, which could improve the safety and efficiency of stem cell therapies. The method uses a chemically synthesized ECM and results in stem cells with uncompromised pluripotency.
Researchers at Gladstone Institutes have identified two microRNAs, miR-1 and miR-133, which play a crucial role in controlling the differentiation of pluripotent embryonic stem cells into cardiac muscle. These findings provide insight into fine-tuning cellular processes and may lead to new treatments for heart-related diseases.
A research team led by the Genome Institute of Singapore found that a molecular alliance between specific proteins known as transcription factors sustains the pluripotent embryonic stem cell state. The team identified Klf2 and Klf5 as redundant molecules that substitute for Klf4, maintaining the ES cell state.
Acclaimed stem cell researcher Shinya Yamanaka successfully reprograms human adult cells into pluripotent stem cells capable of developing into any cell type. This breakthrough accelerates the pace of stem cell research and holds promise for generating alternative sources of human pluripotent stem cells.
Two new genes, Jmjd1a and Jmjd2c, play a crucial role in regulating self-renewal of embryonic stem cells. Their depletion promotes differentiation at the expense of self-renewal.
Researchers have found that adult stem cells do not rely on the protein Oct4 to remain undifferentiated. Studies using sensitive assays failed to detect Oct4 in these cells, revealing a different regulation of pluripotency in adult versus embryonic stem cells.
Researchers at UCLA successfully reprogrammed normal tissue cells into cells with unlimited properties as embryonic stem cells, offering a promising alternative to current cloning methods. The breakthrough could lead to the creation of immune-compatible cells for disease treatment and regenerative therapies.
Researchers successfully induced pluripotent cells from fibroblasts using four transcription factors, exhibiting properties similar to embryonic stem cells. These findings have significant implications for regenerative medicine and may pave the way for generating patient-specific stem cell lines directly from a person's own cells.
Researchers have successfully induced differentiated adult cells to behave like embryonic stem cells using only four factors. This breakthrough enables the creation of pluripotent cells directly from a patient's own cells, potentially revolutionizing the treatment of diseases such as Parkinson's disease and diabetes.
Researchers have successfully induced differentiated adult cells to behave like embryonic stem cells using only four factors. The discovery could revolutionize the treatment of diseases such as Parkinson's and diabetes by providing a direct source of pluripotent cells from patients' own cells.
Researchers from Gladstone Institutes have gained a better understanding of the use of stem cells to generate replacement cells for damaged heart muscle and vessels. The study highlights several challenges ahead, including guiding stem cells into cardiac lineage and integrating them safely within patients' heart tissue.
A team of researchers has identified three key transcription factors that enable human embryonic stem cells to maintain pluripotency. By understanding the regulatory circuitry controlling these cells, scientists can now develop strategies to coax them into specific cell types for regenerative medicine applications.